← FDA Drug Approvals (Drugs@FDA)

CANAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2026-04-20

Drug application

FDA Application #

ANDA210386

Application type

Abbreviated New Drug Application (Generic)

Brand name

CANAGLIFLOZIN

Generic name

Canagliflozin

Active ingredients

CANAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AUROBINDO PHARMA LTD

First approval

2026-04-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown